AzTrials
AzTrials

Doctors Attending a Central Line Insertion Training Courses for New Residents of a University Hospital From March 2017 to June 2017NCT03252197

A Randomized Parallel Study for Simulated Internal Jugular Vein Cannulation Using Simple Needle Guide Device

A study testing UGIJVC with needle guide device and UGIJVC without needle guide device in people with Doctors Attending a Central Line Insertion Training Courses for New Residents of a University Hospital From March 2017 to June 2017 and Physicians Who Had Less Than 10 Ultrasound Guided Internal Jugular Vein Cannulation Participate in This Study, run by Yonsei University at 1 site in South Korea.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Two-dimensional ultrasound guided approach does not guarantee first attempt success on internal jugular vein cannulation. New attachable device recently was developed for accurate needle insertion when ultrasound is used. Read more about this study

Who is it for?
Ages 20 years and olderHealthy volunteers can take part
What is being tested?
UGIJVC with needle guide device and UGIJVC without needle guide device
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
88 participants
Where
1 siteSouth Korea
Study dates
11 Mar 2017to 24 Jun 2017
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 20 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Adults over 20
  • Resident in clinical hospital
  • Ultrasound-guided internal jugular vein insertion without supervisor experience less than 10

Who cannot join

  • If they have physical problem that is difficult to perform
  • If they do not want to participate in this study
  • If they can not understand the contents reading the informed consent
  • If they have more than 10 ultrasound guided internal jugular vein insertion without supervisor

Trial locations and contacts

1 site in 1 country.

South Korea1 site
  • Department of Emergency Medicine, Yonsei University College of Medicine, Yonsei University Severance Hospital

    Seoul, 03722

Other trials in South Korea

About this study

Two-dimensional ultrasound guided approach does not guarantee first attempt success on internal jugular vein cannulation. New attachable device recently was developed for accurate needle insertion when ultrasound is used. Our randomized parallel simulation study will examine whether this device will improve the first attempt success rate when ultrasound guided internal jugular vein catheterization of simulated internal jugular vein.

Read the detailed description

This was a prospective, randomized, parallel trial using phantom simulating internal jugular vein.

After informed consent all subjects will be randomized to insert needle for internal jugular vein cannulation of phantom using ultrasound approach with or without this device. Video camera will record all procedure process and ultrasound image in real time. Researchers blinded to the study aim measured outcome variables based on recorded images.

Being tested
UGIJVC with needle guide device, UGIJVC without needle guide device
Keywords
Ultrasound guided central venous cannulation, new device, first attempt success

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • UGIJVC with needle guide deviceDevice

    Study subjects assigned to each group were trained in ultrasound guided internal jugular venous cannulation (UGIJVC) in separate spaces. On each session, subjects were educated about UGIJVC for 30 minutes, and the instructor who was in charge of session, consisted of experienced physicians who had 50 or more UGIJVC success experiences without a supervisor in clinical field. The instructors explained the anatomical structure and the principles of UGIJVC and then demonstrated the procedures directly to the subjects using phantom. After that, all subjects were instructed to perform hands on practice for 30 minutes. In case group, the instructor trained subjects using device. On the other hand in control group, UGIVJC was demonstrated as a conventional method of approaching the target vessel while confirming the needle tip on the ultrasound screen in real time without a device.

  • UGIJVC without needle guide deviceDevice

    Also called Conventional group

    participants who are tested performance for ultrasound guided cannulation using conventional method.

Study groups in NCT03252197
Study groupRoleWhat they receive
New device groupExperimentalparticipants who are tested performance for ultrasound guided cannulation using device
Receives: Device: UGIJVC with needle guide device
Conventional groupActive comparatorparticipants who are tested performance for ultrasound guided cannulation using conventional method
Receives: Device: UGIJVC without needle guide device

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. First attempt success

    The first attempt success was defined as a successful attempt to perform a vein puncture in one attempt. The number of attempts was counted each time a subject inserted a guide needle into the phantom surface, followed by withdrawal, redirect, or reinsertion.

    Measured: Within 2 minutes or after start to insertion attempt

Secondary outcomes (4)
  1. Posterior wall puncture of the internal jugular procedure, comfort level with procedure

    It was defined when the needle tip on the recorded ultrasound screen was confirmed to pass through the posterior wall measurement unit : Yes or no (categorical variable)

    Measured: Within 2 minutes or after start to insertion attempt

  2. Carotid artery puncture

    It was defined as the needle tip passing through the carotid lumen or the subject regurgitating artery water during cannulation attempt.

    measurement unit : Yes or no (categorical variable)

    Measured: Within 2 minutes or after start to insertion attempt

  3. Time to cannulation

    It was defined as the time from time out for procedure start to end point measurement unit : second

    Measured: Within 2 minutes or after start to insertion attempt

  4. Comfort level

    It was defined subjective opinion about difficulty during procedure for each subject measurement unit : 100-mm visual analogue scale with 0 being the least of the difficulties and 10 being the highest.

    Measured: Within 2 minutes or after start to insertion attempt

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted17 Aug 2017
  2. Study start11 Mar 2017
  3. Primary completion24 Jun 2017
  4. Study completion24 Jun 2017

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
88 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03252197
Sponsor's protocol ID
1-2016-0081
Status last verified
Aug 2017
First submitted
28 Jul 2017
Last updated
17 Aug 2017
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing UGIJVC with needle guide device and UGIJVC without needle guide device in people with Doctors Attending a Central Line Insertion Training Courses for New Residents of a University Hospital From March 2017 to June 2017 and Physicians Who Had Less Than 10 Ultrasound Guided Internal Jugular Vein Cannulation Participate in This Study, run by Yonsei University at 1 site in South Korea.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 17 Aug 2017. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in South Korea. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

First attempt success (time frame: Within 2 minutes or after start to insertion attempt). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 17 Aug 2017.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in